Clinical Trial

A Clinical Study of SYS6023 in Patients With Advanced Solid Tumors

Name: A Clinical Study of SYS6023 in Patients With Advanced Solid Tumors — clinical trial record (NCT07110883)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is an open-label, dose-escalation and cohort-expansion, multicenter Phase I study involving participants with advanced solid tumors.

Trial Details

NCT Number	NCT07110883
Lead Sponsor	CSPC Megalith Biopharmaceutical Co.,Ltd.
Conditions	Advanced Solid Tumor
Enrollment	400 participants
Start Date	2024-08-15
Primary Completion	2026-10-31 (estimated)
Study Completion	2028-10-31 (estimated)
Updated on ClinicalTrials.gov	2025-08-08